Complications related to inadequate delivered dose: Recognition and management in acute and chronic dialysis

Complications of Dialysis

Volumn , Issue , 2000, Pages 89-115

  Yeun, Jane Y ^a   Depner, Thomas A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78651516554     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (128)

1. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription on patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981; 305: 1176-1181.
2. Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482.
3. National Kidney Foundation-Dialysis Outcomes Quality Initiative: clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis 1997; 30: S22-S63.
4. Teraoka S, Toma H, Nihei H, Ota K, Babazono T, Ishikawa I, et al. Current status of renal replacement therapy in Japan. Am J Kidney Dis 1995; 25: 151-164.
5. Hull AR, Parker TF. Proceedings from the morbidity, mortality and prescription of dialysis symposium: introduction and summary. Am J Kidney Dis 1990; 15: 375-383.
6. Agodoa LYC, Held PJ, Wolfe RA, Port FK. US Renal Data System 1998 Annual Data Report. 10th ed. Springfield VA: National Technical Information Service, 1998.
7. Lundin PA. Prolonged survival on hemodialysis. In: Maher JF, ed. Replacement of Renal Function by Dialysis. 3rd ed. Dordrecht: Kluwer Academic Publishers, 1989.
8. Hakim RM, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994; 23: 661-669.
9. Parker TF, Husni L, Huang W, Lew N, Lowrie EG. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994; 23: 670-680.
10. Owen WF, Jr., Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329: 1001-1006.
11. Lindsay RM, Spanner E. A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am J Kidney Dis 1989; 13: 382-389.
12. Lindsay RM, Spanner E, Heidenheim RP, LeFebvre JM, Hodsman A, Baird J, et al. Which comes first, Kt/V or PCR-chicken or egg? Kidney Int Suppl 1992; 38: S32-S36.
13. Yeun JY, Kaysen GA. Factors influencing serum albumin in dialysis patients. Am J Kidney Dis. In press.
14. Kopple JD. Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis 1994; 24: 1002-1009.
15. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, et al. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286-1291.
16. Yang C-S, Chen S-W, Chiang C-H, Wang M, Peng SJ, Kan Y-T. Effects of increasing dialysis dose on serum albumin and mortality in hemodialysis patients. Am J Kidney Dis 1996; 27: 380-386.
17. Collins AJ, Ma JZ, Umen A, Keshaviah P. Urea index and other predictors of hemodialysis patient survival [published erratum appears in Am J Kidney Dis 1994; 24(1): 157]. Am J Kidney Dis 1994; 23: 272-282.
18. Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, et al. The dose of hemodialysis and patient mortality. Kidney Int 1996; 50: 550-556.
19. Gotch FA, Levin NW, Port FK, Wolfe RA, Uehlinger DE. Clinical outcome relative to the dose of dialysis is not what you think: the fallacy of the mean. Am J Kidney Dis 1997; 30: 1-15.
20. Depner TA, Beck GJ, Daugirdas JT, Kusek JW, Eknoyan G. Lessons from the hemodialysis (HEMO) Study: An improved measure of the actual hemodialysis dose. Am J Kidney Dis. In press.
21. Laird NM, Berkey CS, Lowrie EG. Modeling success or failure of dialysis therapy: the National Cooperative Dialysis Study. Kidney Int 1983; 23(suppl 13): S101-S106.
22. Vanholder R, Ringoir S. Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol 1993; 3: 1541-1554.
23. Bloembergen WE, Stannard DC, Port FK, Wolfe RA, Pugh JA, Jones CA, et al. Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int 1996; 50: 557-565.
24. Ifudu O, Feldman J, Friedman EA. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 1996; 334: 420-425.
25. Madore F, Lowrie EG, Brugnara C, Lew NL, Lazarus JM, Bridges K, et al. Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol 1997; 8: 1921-1929.
26. Depner TA, Rizwan S, James LA. Effectiveness of low dose erythropoietin: a possible advantage of high flux hemodialysis. ASAIO J 1990; 36: M223-M225.
27. Kolff WJ, Berk HTJ, ter Welle M, van der Ley AJW, van Dijk EC, van Noordwijk J. The artificial kidney, a dialyzer with a great area. Acta Med Scand 1944; 117: 121-128.
28. Bergstrom J, Furst P. Uraemic toxins. In: Drukker W, Parsons FM, Maher JF, eds. Replacement of Renal Function by Dialysis. 2d ed. Boston: Martinus Nijhoff, 1983: 354-390.
29. Vanholder R, Schoots A, Ringoir S. Uremic toxicity. In: Maher JF, ed. Replacement of Renal Function by Dialysis. 3rd ed. Dordrecht: Kluwer Academic Publishers, 1989: 4-19.
30. Mason MF, Resnik H, Mino AS, Rainey J, Pilcher C, Harrison TR. Mechanism of experimental uremia. Arch Intern Med 1993; 60: 312-1937.
31. Merrill JP, Legrain M, Hoigne R. Observations on the role of urea in uremia. Am J Med 1953; 14: 519-520.
32. Johnson WJ, Hagge WW, Wagoner RD, Dinapoli RP, Rosevear JW. Effects of urea loading in patients with far-advanced renal failure. Mayo Clin Proc 1972; 47: 21-29.
33. Fluckiger R, Harmon W, Meier W, Loo S, Gabbay KH. Hemoglobin carbamylation in uremia. N Engl J Med 1981; 304: 823-827.
34. Kwan JTC, Carr EC, Neal AD, Burdon J, Raferty MJ, Marsh FP, et al. Carbamylated haemoglobin, urea kinetic modelling and the adequacy of dialysis in haemodialysis patients. Nephrol Dial Transpl 1991; 6: 38-43.
35. Davenport A, Jones S, Goel S, Astley JP, Feest TG. Carbamylated hemoglobin: a potential marker for the adequacy of hemodialysis therapy in end-stage renal failure. Kidney Int 1996; 50: 1344-1351.
36. Smith HW. The Kidney. New York: Oxford University Press, 1951.
37. Schreiner GE, Maher JF. Uremia: Biochemistry, Pathogenesis and Treatment. Springfield IL: Charles C Thomas, 1961.
38. Depner TA. The uremic syndrome. In: Greenberg A, ed. NKF Primer on Kidney Diseases. San Diego: Academic Press, Inc., 1994: 253-258.
39. Gotch FA. Kinetic modeling in hemodialysis. In: Nissenson AR, Fine RN, Gentile DE, eds. Clinical Dialysis. 3rd ed. Norwalk, CT: Appleton and Lange, 1995: 156-188.
40. Daugirdas JT, Depner TA, Gotch FA, Greene T, Keshaviah PR, Levin NW, et al. Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 1997; 52: 1395-1405.
41. Depner TA, Keshaviah PR, Ebben JP, Emerson PF, Collins AJ, Jindal KK, et al. Multicenter clinical validation of an on-line monitor of dialysis adequacy. J Am Soc Nephrol 1996; 7: 464-471.
42. Bergstrom J. Nutrition and adequacy of dialysis in hemodialysis patients. Kidney Int Suppl 1993; 41: S261-267.
43. Depner TA. Quantifying hemodialysis. Am J Nephrol 1996; 16: 17-28.
44. Giovannetti S, Balestri PL, Barsotti G. Methylguanidine in uremia. Arch Intern Med 1973; 131: 709-713.
45. Leypoldt JK, Cheung AK, Agodoa LY, Daugirdas JT, Greene T, Keshaviah PR. Hemodialyzer mass transferarea coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney Int 1997; 51: 2013-2017.
46. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534.
47. Daugirdas JT, Schneditz D. Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J 1995; 41: M719-724.
48. Mahmood I, Balian JD. Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. Xenobiotica 1998; 87: 527-529.
49. Bachmann K, Pardoe D, White D. Scaling basic toxicokinetic parameters from rat to man. Environ Health Perspect 1996; 104: 400-407.
50. West GB, Brown JH, Enquist BJ. A general model for the origin of allometric scaling laws in biology. Science 1997; 276: 122-126.
51. Schmidt-Nielsen K. Scaling: Why is animal size so important? In: CalderWA, ed. Size, Function, and Life History. Cambridge, MA: Harvard University Press, 1984.
52. Edwards NA. Scaling of renal functions in mammals. Comp Biochem Physiol A 1975; 52: 63-66.
53. Casino FG, Lopez T. The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transpl 1996; 11: 1574-1581.
54. Depner TA. Prescribing hemodialysis: A Guide to Urea Modeling. Boston: Kluwer Academic Publishers, 1991.
55. Smye SW, Will EJ. A mathematical analysis of a twocompartment model of urea kinetics. Phys Med Biol 1995; 40: 2005-2014.
56. Schneditz D, Daugirdas JT. Formal analytical solution to a regional blood flow and diffusion based urea kinetic model. ASAIO J 1994; 40: M667-673.
57. Depner TA, Rizwan S, Cheer AY, Wagner JM, Eder LA. High venous urea concentrations in the opposite arm. A consequence of hemodialysis-induced compartment disequilibrium. ASAIO J 1991; 37: M141-143.
58. Schneditz D, Kaufman AM, Polaschegg HD, Levin NW, Daugirdas JT. Cardiopulmonary recirculation during hemodialysis. Kidney Int 1992; 42: 1450-1456.
59. Depner TA. Multicompartment models. In: Prescribing Hemodialysis: A Guide to Urea Modeling. Boston: Kluwer Academic Publishers, 1991: 91-126.
60. Daugirdas J, Greene T, Depner T, Gotch F, Keshaviah P, Star R. Estimation of double pool volume from single pool urea distribution volume (abstr). J Am Soc Nephrol 1996; 7: 1510.
61. NIH Consensus Conference. Consensus development conference panel: morbidity and mortality of renal dialysis: an NIH consensus conference statement. Ann Intern Med 1994; 121: 62-70.
62. Renal Physicians Association Clinical Practice Guideline on Adequacy of Hemodialysis. Washington, DC: Renal Physicians Association, 1993.
63. Borah MF, Schoenfeld PY, Gotch FA, Sargent JA, Wolfson M, Humphreys MH. Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 1978; 14: 491-500.
64. Buur T. Two-sample hemodialysis urea kinetic modeling: validation of the method. Nephron 1995; 69: 49-53.
65. Depner TA. Single-compartment model. In: Prescribing Hemodialysis: A Guide to Urea Modeling. Boston: Kluwer Academic Publishers, 1991: 65-89.
66. Depner TA. Assessing adequacy of hemodialysis: urea modeling. Kidney Int 1994; 45: 1522-1535.
67. Krivitski NM, Kishlukhim V, Snyder J, MacGibbon D, Reasons AM, Depner T. A method for measuring dialyzer blood volume in vivo: theory and validation (abstr). J Am Soc Nephrol 1997; 8: 770.
68. Dewanjee MK, Kapadvanjwala M, Cavagnaro CF, Panoutsopoulos GK, Suguihara CY, Elson R, et al. In vitro and in vivo evaluation of the comparative thrombogenicity of cellulose acetate hemodialyzers with radiolabeled platelets. ASAIO J 1994; 40: 49-55.
69. Dewanjee MK, Kapadvanjwala M, Ruzius K, Serafini AN, Zilleruelo GE, Sfakianakis GN. Quantitation of thrombogenicity of hemodialyzer with technetium-99m and indium-111 labeled platelets. Nuclear Med Biol 1994; 40: 49-55.
70. Keshaviah PR, Ebben JP, Emerson PF. On-line monitoring of the delivery of the hemodialysis prescription. Pediatr Nephrol 1995; 9: S2-S8.
71. Garred LJ, Rittau M, McCready W, Canaud B. Urea kinetic modelling by partial dialysate collection. Int J Artif Organs 1989; 12: 96-102.
72. Garred LJ. Dialysate-based kinetic modeling. Adv Ren Replace Ther 1995; 2: 305-318.
73. Keshaviah P. The solute removal index-a unified basis for comparing disparate therapies [editorial]. Perit Dial Int 1995; 15: 101-104.
74. Keshaviah P, Star RA. A new approach to dialysis quantification: an adequacy index based on solute removal. Semin Dial 1994; 7: 85-90.
75. Depner TA, Greene T, Gotch FA, Daugirdas JT, Keshaviah PR, Star RA. Imprecision of the hemodialysis dose when measured directly from urea removal. Kidney Int. In press.
76. Tattersall JE, DeTakats D, Chamney P, Greenwood RN, Farrington K. The post-hemodialysis rebound: predicting and quantifying its effect on Kt/V. Kidney Int 1996; 50: 2094-2102.
77. Evans JH, Smye SW, Brocklebank JT. Mathematical modelling of haemodialysis in children. Pediatr Nephrol 1992; 6: 349-353.
78. Leblanc M, Charbonneau R, Lalumière G, Cartier P, Déziel C. Postdialysis urea rebound: determinants and influence on dialysis delivery in chronic hemodialysis patients. Am J Kidney Dis 1996; 27: 253-261.
79. Henderson LW. Of time, TACurea, and treatment schedules. Kidney Int 1988; 33(suppl 24): S105-S106.
80. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33: 27-39.
81. Hume R, Weyers E. Relationship between total body water and surface area in normal and obese subjects. J Clin Pathol 1971; 24: 234-238.
82. Chertow GM, Lazarus JM, Lew NL, Ma L, Lowrie EG. Development of a population-specific regression equation to estimate total body water in hemodialysis patients. Kidney Int 1997; 51: 1578-1582.
83. Depner TA. Refinements and application of urea modeling. In: Prescribing Hemodialysis: A Guide to Urea Modeling. Boston: Kluwer Academic Publishers, 1991: 168-194.
84. Depner TA. Benefits of more frequent dialysis: lower TAC at the same Kt/V. Nephrol Dial Transpl 1998; 13: 20-24.
85. Lysaght MJ, Vonesh E, Gotch F, Ibels L, Keen M, Lindholm B, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO J 1991; 37: 598-604.
86. Van Stone JC. The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients. ASAIO J 1996; 41: M713-M716.
87. National Kidney Foundation-Dialysis Outcomes Quality Initiative: clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 1997; 30: S70-S136.
88. Mars DR, Doll MA. Uremic pericarditis in a chronic hemodialysis patient. Dial Transpl 1993; 22: 23-26.
89. Depner TA, Rizwan S, Stasi TA. Pressure effects on roller pump blood flow during hemodialysis. ASAIO J 1990; 36: M456-M459.
90. Sands J, Glidden D, Jacavage W, Jones B. Difference between delivered and prescribed blood flow in hemodialysis. ASAIO J 1996; 42: M717-719.
91. Wolfson M. Use of nutritional supplements in dialysis patients. Semin Dial 1992; 5: 285-290.
92. Kloppenburg WD, Wolthers BG, Tepper T, Stegeman CA, de Jong PE, Huisman RM. Fluctuations of urea generation rate following protein intake in hemodialysis patients measured using [13-C]urea (abstr). J Am Soc Nephrol 1995; 6: 581.
93. McCann L, Feldman C, Hornberger J. Effect of intradialytic parenteral nutrition on delivered Kt/V (abstr). Am J Kidney Dis 1997; 29: 11.
94. Depner TA. Pitfalls in quantitating hemodialysis. Semin Dial 1993; 6: 127-133.
95. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213.
96. Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995; 2: 295-304.
97. Depner TA, Daugirdas JT. Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 1996; 7: 780-785.
98. Daugirdas JT, Depner TA. A nomogram approach to hemodialysis urea modeling. Am J Kidney Dis 1994; 23: 33-40.
99. Depner TA. Estimation of Kt/V from URR for varying levels of weight loss: a bedside graphic aid. Semin Dial 1993; 6: 242.
100. Scribner BH, Farrell PC, Milutinovic J, Babb AL. Evolution of the middle molecule hypothesis. In: Villarreal H, ed. Proceedings of the Fifth International Congress of Nephrology. Basel: Karger, 1974: 190-199.
101. Eknoyan G, Levey AS, Beck GJ, Agodoa LY, Daugirdas JT, Kusek JW, et al. The hemodialysis (HEMO) study: rationale for selection of interventions. Semin Dial 1996; 9: 24-33.
102. Depner TA. Quantifying hemodialysis and peritoneal dialysis: examination of the peak concentration hypothesis. Semin Dial 1994; 7: 315-317.
103. Gotch FA. The current place of urea kinetic modeling with respect to different dialysis modalities. Nephrol Dial Transpl 1998; 13: 10-14.
104. Kaplan MA, Hays L, Hays RM. Evolution of a facilitated diffusion pathway for amides in the erythrocyte. Am J Physiol 1974; 226: 1327-1332.
105. Macey RI, Yousef LW. Osmotic stability of red cells in renal circulation requires rapid urea transport. Am J Physiol 1988; 254: C669-C674.
106. Buoncristiani U, Quintaliani G, Cozzari M, Giombini L, Ragaiolo M. Daily dialysis: long-term clinical metabolic results. Kidney Int 1988; 33: S137-S140.
107. Uldall R, Ouwendyk M, Francoeur R, Wallace L, Sit W, Vas S, et al. Slow nocturnal home hemodialysis at the Wellesley Hospital. Adv Ren Replace Ther 1996; 3: 133-136.
108. Pierratos A, Ouwendyk M, Francoeur B, Wallace L, Sit W, Vas S, et al. Slow nocturnal home hemodialysis. Dial Transpl 1995; 24: 557-576.
109. Leblanc M, Tapolyai M, Paganini EP. What dialysis dose should be provided in acute renal failure? A review. Adv Ren Replace Ther 1995; 26: 910-917.
110. Clark WR, Mueller BA, Kraus MA, Macias WL. Dialysis prescription and kinetics in acute renal failure. Adv Ren Replace Ther 1997; 4: 64-71.
111. Bellomo R, Mehta R. Acute renal replacement in the intensive care unit: now and tomorrow. N Horiz 1995; 3: 760-767.
112. Mehta RL. Therapeutic alternatives to renal replacement for critically ill patients in acute renal failure. Semin Nephrol 1994; 14: 64-82.
113. Ward DM, Mehta RL. Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int Suppl 1993; 41: S237-244.
114. Paganini EP, Halstenberg WK, Goormastic M. Risk modeling in acute renal failure requiring dialysis: the introduction of a new model. Clin Nephrol 1996; 46: 206-211.
115. Lo AJ, Depner TA, Chin ES, Craig MA. Urea disequilibrium contributes to underdialysis in the intensive care unit (abstr). J Am Soc Nephrol 1997; 8: 287.
116. Jaber BL, King AJ, Cunniff PJ, Cendoroglo MN, Sundaram S, Pereira BJG. Prescribed versus delivered dose of intermittent hemodialysis in acute renal failure: a substantial discrepancy (abstr). J Am Soc Nephrol 1997; 8: 284.
117. Mulhern JG, O’Shea MH, Germain MJ, Lipkowitz GS, Madden RL, Sweet SJ, et al. Reduced dialysis adequacy in hospitalized hemodialysis patients (abstr). J Am Soc Nephrol 1997; 8: 289.
118. Depner TA, Krivitski NM. Clinical measurement of blood flow in hemodialysis access fistulae and grafts by ultrasound dilution. ASAIO J 1995; 41: 745-749.
119. Mehrotra R, Nolph KD, Gotch F. Early initiation of chronic dialysis: role of incremental dialysis [editorial]. Perit Dial Int 1997; 17: 426-430.
120. Daugirdas JT, Smye SW. Effect of a two compartment distribution on apparent urea distribution volume. Kidney Int 1997; 51: 1270-1273.
121. Ronco C, Crepaldi C, Brendolan A, La Greca G. Intradialytic exercise increases effective dialysis efficiency and reduces rebound (abstr). J Am Soc Nephrol 1995; 6: 612.
122. George TO, Priester CA, Dunea G, Schneditz D, Tarif N, Daugirdas JT. Cardiac output and urea kinetics in dialysis patients: evidence supporting the regional blood flow model. Kidney Int 1997; 52: 1395-1405.
123. Depner T, Rizwan S, Cheer A, Wagner J. Peripheral urea disequilibrium during hemodialysis is temperature- dependent (abstr). J Am Soc Nephrol 1991; 2: 321.
124. Daugirdas JT, Schneditz D, Leehey DJ. Effect of access recirculation on the modeled urea distribution volume. Am J Kidney Dis 1996; 27: 512-518.
125. Daugirdas JT, Burke MS, Balter P, Priester CA, Majka T. Screening for extreme postdialysis urea rebound using the Smye method: patients with access recirculation identified when a slow flow method is not used to draw the postdialysis blood. Am J Kidney Dis 1997; 51: 1270-1273.
126. Parker TF, Laird NM, Lowrie EG. Comparison of the study groups in the National Cooperative Dialysis Study and a description of morbidity, mortality, and patient withdrawal. Kidney Int 1983; 23: S42-S49.
127. Depner TA. Approach to hemodialysis kinetic modeling. In: Henrich WL, ed. Principles and Practice of Dialysis. 2d ed. Baltimore: Williams & Wilkins, 1998.
128. Sands J, Jabayc P, Miranda C. Delivered blood flow in cuffed central venous dialysis catheters (abstr). ASAIO J 1997; 43: 69.